The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased NewAge, Inc. (OTC: NBEVQ) securities between January 18, 2018 and October 18, 2022, for violations of the Securities Exchange Act of 1934. NewAge purports to produce and sell various beverages and other health products.
What Now: Similarly situated shareholders may be eligible to participate in the class action against the officers and directors of NewAge. Shareholders who want to act as lead plaintiff for the class must file their papers by February 6, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
What is this Case About: The Officers and Directors of NewAge, Inc. (NBEVQ) Caused the Company to Issue False and Misleading Statements Regarding its Business Prospects
According to the complaint, during the class period, defendants made a series of false and misleading statements concerning distribution agreements and partnerships with the U.S. military, expanded distribution of products to “all major retailers throughout Canada…”, and agreements “with the largest food and beverage distributor in South Korea to expand to all major retail outlets throughout the country immediately.” Defendants also made misleading statements regarding testing and developing CBD-infused beverages. Finally, defendants made misleading statements regarding its distribution agreement with Walmart.
In December 2020, NewAge completed its acquisition of Ariix. Thereafter, it developed concerns that Ariix had violated the Foreign Corrupt Practices Act (“FCPA”). In August 2021, NewAge made a voluntary self-disclosure of suspected FCPA issues to the U.S. Department of Justice and the SEC. The Company further disclosed that as of June 30, 2021, a material weakness existed relating to the Company’s “failure to design and implement monitoring activities over the acquisition of Ariix that resulted in the ability to issue our consolidated financial statements [. . .].”
On January 10, 2022, NewAge announced defendant Brent Willis would resign as CEO, Director, and employee of the Company. NewAge announced it was filing for Chapter 11 bankruptcy relief on August 30, 2022. As a result, the Company’s stock stopped trading on September 8, 2022.
On October 18, 2022, the SEC announced it was taking legal action against defendant Willis as he engaged in a “multi-year fraud by disseminating numerous false and misleading press releases and making false public statements concerning NewAge’s business dealings, and aided and abetted NewAge’s disclosure of material information in violation of Regulation FD.”
Contact us to learn more:
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against NewAge, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.